P0689

(R)-(+)-普奈洛尔 盐酸盐

≥98% (TLC)

• 同義詞: (R)-1-(异丙基氨基)-3-(1-萘氧基)-2-丙醇 盐酸盐
• 線性公式: C₁₀H₇OCH₂CH(OH)CH₂NHCH(CH₃)₂·HCl
• CAS號碼: 13071-11-9
• 分子量：: 295.80
• Beilstein: 5780490
• EC號碼: 235-961-7
• MDL號碼: MFCD00064546
• 分類程式碼代碼: 12352200
• PubChem物質ID: 24898124
• NACRES: NA.77

屬性

• 品質等級: 200
• 化驗: ≥98% (TLC)
• mp: 196-198 °C (lit.)
• 溶解度: ethanol: 10 mg/mL; DMSO: <14.5 mg/mL; H₂O: 50 mg/mL; 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 8.0 mg/mL
• 起源: AstraZeneca
• 儲存溫度: 2-8°C
• SMILES 字串: Cl.CC(C)NC[C@@H](O)COc1cccc2ccccc12
• InChI: 1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H/t14-;/m1./s1
• InChI 密鑰: ZMRUPTIKESYGQW-PFEQFJNWSA-N

描述

一般說明

With heat. Aqueous solutions are most stable at pH 3.0 and decompose rapidly at basic pH. Decomposition is accompanied by discoloration of the solution.

生化／生理作用

普奈洛尔活性较低的对映体。

特點和優勢

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302
• 防範說明: P264 - P270 - P301 + P312 - P501
• 危險分類: Acute Tox. 4 Oral
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: dust mask type N95 (US), Eyeshields, Gloves